Projects per year
Personal profile
Teaching
Professor MacDonald's research covers the efficacy, benefits and risks of medicines and cardiovascular disease: clinical trials and drug epidemiology
Fingerprint
Dive into the research topics where Thomas MacDonald is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 54 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Allopurinol and Cardiovascular Outcomes in Patients with Ischaemic Heart Disease (Joint with Robertson Centre for Biostatistics, University of Nottingham and University College London)
MacDonald, T., Mackenzie, I. & Struthers, A.
National Institute for Health Research
1/09/13 → 1/04/21
Project: Research
-
-
The Impact of EU Label Changes for Diclofenac
MacDonald, T., Mackenzie, I. & Morales, D.
6/09/17 → 5/03/19
Project: Research
Research Output
-
Chronotherapy in hypertension: the devil is in the details
Guthrie, G., TIME study Steering Committee, Poulter, N., Macdonald, T., Ford, I., Mackenzie, I., Findlay, E., Williams, B., Brown, M., Lang, C. & Webb, D., 21 Apr 2020, In : European Heart Journal. 41, 16, p. 1606-1607 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method
Rogers, A., Craig, G., Flynn, A., Mackenzie, I., MacDonald, T. & Doney, A., 5 Jun 2020, In : Trials. 21, 1, p. 1-5 5 p., 477.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
COX-2 inhibitors: Communication of accumulating risk evidence and a product withdrawal
Rogers, A., Grieve, K. & MacDonald, T. M., 2020, Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research. Bahri, P. (ed.). Singapore: Adis, p. 131-146 16 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands
Morales, D. R., Morant, S. V., MacDonald, T. M., Mackenzie, I. S., Doney, A. S. F., Mitchell, L., Bennie, M., Robertson, C., Hallas, J., Pottegard, A., Ernst, M. T., Wei, L., Nicholson, L., Morris, C., Herings, R. M. C., Overbeek, J. A., Smits, E. & Flynn, R. W. V., Mar 2020, In : Pharmacoepidemiology and Drug Safety. 29, 3, p. 296-305 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)52 Downloads (Pure) -
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: interrupted time series regression analysis
Morales, D. R., Morant, S. V., MacDonald, T. M., Hallas, J., Ernst, M. T., Pottegard, A., Herings, R. M. C., Smits, E., Overbeek, J. A., Mackenzie, I. S., Doney, A. S. F., Mitchell, L., Bennie, M., Robertson, C., Wei, L., Nicholson, L., Morris, C. & Flynn, R. W. V., 15 Jul 2020, In : British Journal of Clinical Pharmacology. 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Press / Media
-
High salt levels in common medicines put patients at increased risk of cardiovascular events
Jacob George, Thomas M MacDonald & Isla S. Mackenzie
26/11/13
1 item of Media coverage
Press/Media: Research
-
Blood tests pick up early 'silent' heart disease
Adnan Nadir, Sushma Rekhraj, Li Wei, Tiong Lim, John Davidson, Thomas M MacDonald, Chim C. Lang, Eleanor Dow & Allan D. Struthers
24/09/12
1 item of Media coverage
Press/Media: Research